Summary:
This study is looking to gain long-term data on Inclisiran, an FDA-approved medication for high cholesterol treatment. Participants who have had a heart attack, stroke, or have been diagnosed with peripheral arterial disease (PAD) and are taking a statin class of medication may qualify to participate.
Qualified Participants Must:
• 40+ years of age
• Taking a statin medication for lowering cholesterol
• Have had either a heart attack, ischemic stroke, or diagnosed with peripheral arterial disease (PAD)
Qualified Participants May Receive:
Those who meet the criteria for study participants may receive compensation for time and travel, $65.00 for each office visit.